Skip to content
Lower risk Drug recall · FDA · Published October 28, 2025

Sun Pharmaceutical Lisdexamfetamine Capsules Recall: Failed Dissolution Test

Sun Pharmaceutical recalls 60mg Lisdexamfetamine Dimesylate capsules with failed dissolution tests. This may affect medication stability. Contact for return instructions.

🇺🇸 FDA recall #D-0149-2026DrugSun Pharmaceutical ›
Take action

Contact the company

Recalling firmSUN PHARMACEUTICAL INDUSTRIES INC2 Independence Way · Princeton, NJ 08540-6620
✎ GovInfoNow plain-language explainer

Sun Pharmaceutical is recalling 60mg Lisdexamfetamine Dimesylate capsules that failed stability tests. This could mean the medication doesn't work properly over time, especially for people needing long-term treatment. Read more at govinfonow.com/recall/31668-sun-pharmaceutical-lisdexamfetamine-capsules-recall-failed-dissolution-test.

Source Summary by GovInfoNow · govinfonow.com/recall/31668-sun-pharmaceutical-lisdexamfetamine-capsules-recall-failed-dissolution-test · Updated August 18, 2026 · FDA enforcement record: FDA #D-0149-2026

Cite this page

“Sun Pharmaceutical Lisdexamfetamine Capsules Recall: Failed Dissolution Test.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/31668-sun-pharmaceutical-lisdexamfetamine-capsules-recall-failed-dissolution-test. Based on FDA recall #D-0149-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0149-2026%22&limit=1).

The FDA announced on Oct. 28, 2025, that Sun Pharmaceutical Industries Inc. is voluntarily recalling Lisdexamfetamine Dimesylate Capsules due to failed dissolution specifications. The recall affects specific lots distributed nationwide.

How to tell if you have it

  • Brand: Sun Pharmaceutical
  • Product: Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle
  • NDC: 57664-051-88
  • Lot codes: AD48711 (Expiry: 4/30/2026), AD50896 (Expiry: 5/31/2026)
  • Manufacturer: OHM Laboratories, New Brunswick, NJ
  • Distributor: Sun Pharmaceutical Industries, Inc., Cranbury, NJ

The hazard

GovInfoNow's records show the hazard is failed dissolution specifications resulting from out-of-specification results observed during a 12-month long-term stability test at 25°C and 60% relative humidity. The FDA classifies this as a Class II recall.

Context

GovInfoNow's records show Sun Pharmaceutical has 92 other recalls on record since May 21, 2013. Recent brand recalls include a Carbamazepine Tablets recall for black spots on Aug. 3, 2026, and a Perampanel 6mg Tablets recall for label mix-ups on June 17, 2026. Other recent recalls of similar products include Lannett Niacin Extended-release Tablets Recall (May 27, 2026), Golden State NIACIN Extended-Release Tablets Recall (May 29, 2026), and Supernus Trokendi XR 50mg Capsules (Aug. 31, 2026).

How to tell if you have this one

Check for the product name 'Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle'. Look for lot numbers AD48711 (expiring 4/30/2026) or AD50896 (expiring 5/31/2026).

  • Brand
    Sun Pharmaceutical
  • Category
    Drug
FDA recall event · 7 products

All 7 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    U.S Nationwide.
  • NDC
    57664-047-88, 57664-046-88, 57664-048-88, 57664-049-88, 57664-050-88, 57664-051-88, 57664-052-88, 57664-083-88, 57664-084-88, 57664-085-88, 57664-086-88, 57664-087-88, 57664-088-88
Recall numberProduct, codes & lots
D-0144-2026Lisdexamfetamine Dimesylate Capsules, 10 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-046-88.; Lot #: AD42468, Expiry: 2/28/2026; AD48705, Expiry: 4/30/2026.
D-0145-2026Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-047-88.; Lot #: AD42469, Expiry: 2/28/2026; AD48707, Expiry:4/30/2026.
D-0146-2026Lisdexamfetamine Dimesylate Capsules, 30 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-048-88.; Lot #: AD42470, Expiry: 2/28/2026; AD48708, Expiry:4/30/2026.
D-0147-2026Lisdexamfetamine Dimesylate Capsules, 40 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-049-88.; Lot #: AD48709, Expiry: 4/30/2026; AD50894, Expiry: 5/31/2026.
D-0148-2026Lisdexamfetamine Dimesylate Capsules, 50 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-050-88.; Lot #:AD48710, Expiry: 4/30/2026; AD50895, Expiry: 5/31/2026.
D-0149-2026Lisdexamfetamine Dimesylate Capsules, 60 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-051-88.; Lot #: AD48711, Expiry: 4/30/2026; AD50896, Expiry: 5/31/2026.
D-0150-2026Lisdexamfetamine Dimesylate Capsules, 70 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-052-88.; Lot #: AD48712, Expiry: 4/30/2026; AD50898, Expiry: 5/31/2026.
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the lot numbers AD48711 or AD50896 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 8 days after the firm started it.

1. Firm started the recall: Oct 28, 202512. FDA classified it Class II: Oct 30, 202523. Published in FDA’s Enforcement Report: Nov 5, 202532025
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Are there any safety risks?

The recall indicates potential reduced effectiveness, not immediate safety risks.

Similar recalls

Other Sun Pharmaceutical recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0149-2026 (October 28, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0149-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA